| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997038663A3 Buccal, non-polar spray or capsule |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | WO1997033912A3 Uses of gdnf and gdnf receptor |
| 02/05/1998 | WO1997033620A3 Compounds for treating tumours |
| 02/05/1998 | DE4447715C2 Oestrogen compsn contg. 3-sulphamoyl:oxy-oestratriene cpd. |
| 02/05/1998 | DE4447714C2 Oestrogen compsn contg. 3-sulphamoyl:oxy-oestratriene cpd. |
| 02/05/1998 | DE19631189A1 Neuartige kationische Amphiphile für den liposomalen Gentransfer Novel cationic amphiphiles for the liposomal gene transfer |
| 02/05/1998 | DE19631122A1 Verwendung von Ursodeoxycholsäure bei HIV-Infektion Use of ursodeoxycholic acid in HIV infection |
| 02/05/1998 | DE19631084A1 Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut Use of (meth) acrylic acid copolymers to increase the permeability of the mucosal |
| 02/05/1998 | DE19630814A1 Substituierte N-Isothiazolyl-(thio)amide N-substituted isothiazolyl (thio) amides |
| 02/05/1998 | CA2627035A1 Crystal form i of clarithromycin |
| 02/05/1998 | CA2262564A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition |
| 02/05/1998 | CA2262542A1 Novel compounds and compositions for treating diseases associated with tryptase activity |
| 02/05/1998 | CA2262533A1 2-methoxyestradiol and p53-induced apoptosis in cancer cells |
| 02/05/1998 | CA2262434A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents |
| 02/05/1998 | CA2262092A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | CA2262089A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | CA2262088A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 02/05/1998 | CA2261974A1 Molecular model for vla-4 inhibitors |
| 02/05/1998 | CA2261851A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same |
| 02/05/1998 | CA2261814A1 Potassium channel inhibitors |
| 02/05/1998 | CA2261813A1 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist |
| 02/05/1998 | CA2261808A1 1-azoniabicyclo¬2.2.1|heptane derivatives and pharmaceutical compositions containing them |
| 02/05/1998 | CA2261793A1 Phosphatase inhibitors and methods of use thereof |
| 02/05/1998 | CA2261781A1 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
| 02/05/1998 | CA2261765A1 Methods of treatment of eye trauma and disorders |
| 02/05/1998 | CA2261764A1 Dietary supplements |
| 02/05/1998 | CA2261748A1 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 02/05/1998 | CA2261718A1 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | CA2261708A1 Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
| 02/05/1998 | CA2261692A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
| 02/05/1998 | CA2261689A1 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 02/05/1998 | CA2261687A1 Oral contraceptive |
| 02/05/1998 | CA2261588A1 Pyranoindole and carbazole inhibitors of cox-2 |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261563A1 Human proteolipid |
| 02/05/1998 | CA2261339A1 Novel p-terphenyl compounds |
| 02/05/1998 | CA2261233A1 Formulation for the treatment and/or prophylaxis of dementia |
| 02/05/1998 | CA2261167A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity |
| 02/05/1998 | CA2260956A1 Amino acid compositions and use thereof in immunosuppression |
| 02/05/1998 | CA2260900A1 Substituted triazolo pyridazine derivatives as inverse agonists of the gabaa.alpha.5 receptor subtype |
| 02/05/1998 | CA2260886A1 Amino acid composition and use thereof in treating tumor growth and metastasis |
| 02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
| 02/05/1998 | CA2260047A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 02/05/1998 | CA2259924A1 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | CA2259129A1 Pro-protein converting enzyme |
| 02/05/1998 | CA2258609A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 02/05/1998 | CA2257421A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents |
| 02/05/1998 | CA2257412A1 Water-miscible esters of monoglycerides having antimicrobial activity |
| 02/05/1998 | CA2253521A1 Synthesis of .beta.-lactam antibacterials using soluble side chain esters and enzyme acylase |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0822194A1 FUSED IMIDAZO 1,2-a]PYRIDINES |
| 02/04/1998 | EP0822192A2 Inhibitors of beta-glucuronidase |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0822185A1 B-3-adrenergic agonists as antidiabetic and antiobesity agents |
| 02/04/1998 | EP0822182A1 Substituted indanylidineacetylguanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
| 02/04/1998 | EP0822178A1 New rhein derivatives and new processes for producing rhein derivatives |
| 02/04/1998 | EP0822177A1 Process for producing rhein and diacerhein |
| 02/04/1998 | EP0821965A2 Use of copolymers of (meth)accrylic and maleic acid for the manufacture of a medicament for enhancing the permeability of the mucose |
| 02/04/1998 | EP0821964A2 Use of adenosine and adenosine derivatives for analgesia and attenuation of stress or stress responses |
| 02/04/1998 | EP0821963A1 Anticancer substance suppressing cancerous metastasis |
| 02/04/1998 | EP0821962A1 Use of a phosphoric acid diester for the manufacture of a medicament for the treatment of acne |
| 02/04/1998 | EP0821961A1 Neovascularization inhibitor |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821959A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal |
| 02/04/1998 | EP0821958A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression |
| 02/04/1998 | EP0821957A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse |
| 02/04/1998 | EP0821956A1 Method for treating disruptive behavior disorders |
| 02/04/1998 | EP0821955A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating bipolar disorder |
| 02/04/1998 | EP0821954A1 Method for treating mental retardation |
| 02/04/1998 | EP0821953A2 Anticoccidial methods and feedstuffs |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821951A1 Process for preparing a bicarbonate-containing infusion- or dialysis solution |
| 02/04/1998 | EP0821950A2 Clear hydroalcoholic solution of multivitamins containing physiologically active quantity of beta-carotene |
| 02/04/1998 | EP0821948A2 Combination of active ingredients based on partial glycerides and dialkylsubstituted acetic acids efficient against bacteria, mycoses and viruses |
| 02/04/1998 | EP0821943A2 Cosmetic and dermatological sunscreening formulations containing triazine derivatives and sorbitan-monoesters |
| 02/04/1998 | EP0821740A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
| 02/04/1998 | EP0821736A1 Bacteriocins |
| 02/04/1998 | EP0821692A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 02/04/1998 | EP0821690A1 Novel compounds and methods for therapy |
| 02/04/1998 | EP0821689A1 Tumor protease activated prodrugs of phosphoramide mustard analogs |
| 02/04/1998 | EP0821687A1 Preparation of clavulanate salts |
| 02/04/1998 | EP0821686A1 Novel porphyrins and porphyrin synthesis techniques |
| 02/04/1998 | EP0821685A1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
| 02/04/1998 | EP0821684A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 02/04/1998 | EP0821683A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 02/04/1998 | EP0821682A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
| 02/04/1998 | EP0821681A1 Naphthalene derivatives, method of preparation and use |
| 02/04/1998 | EP0821680A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 02/04/1998 | EP0821676A1 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
| 02/04/1998 | EP0821675A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors |
| 02/04/1998 | EP0821674A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 02/04/1998 | EP0821673A1 New form of (e)-3- 6- (2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
| 02/04/1998 | EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 02/04/1998 | EP0821665A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |